UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Clinical use of dendritic cells for cancer therapy

The lancet oncology, 2014-06, Vol.15 (7), p.e257-e267

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma

Journal of hematology and oncology, 2020-12, Vol.13 (1), p.164-14, Article 164

2020

Link zum Volltext

Verfügbarkeit prüfen

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

Cells (Basel, Switzerland), 2020-07, Vol.9 (7), p.1720

2020

Link zum Volltext

Verfügbarkeit prüfen

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs

Pharmacology & therapeutics (Oxford), 2015-02, Vol.146, p.120-131

2015

Link zum Volltext

Verfügbarkeit prüfen

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

Journal of translational medicine, 2022-03, Vol.20 (1), p.124-124, Article 124

2022

Link zum Volltext

Verfügbarkeit prüfen

Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia

Cancers, 2021-09, Vol.13 (18), p.4519

2021

Link zum Volltext

Verfügbarkeit prüfen

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Cancers, 2019-10, Vol.11 (10), p.1597

2019

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Frontiers in immunology, 2018-03, Vol.9, p.394-394

2018

Link zum Volltext

Verfügbarkeit prüfen

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

Oncotarget, 2017-10, Vol.8 (52), p.89722-89735

2017

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.101-101, Article 101

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

Cancers, 2019-06, Vol.11 (6), p.872

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones

Frontiers in immunology, 2021-07, Vol.12, p.668962-668962

2021

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

PloS one, 2015-05, Vol.10 (5), p.e0123340-e0123340

2015

Link zum Volltext

Verfügbarkeit prüfen

NK Cells: Key to Success of DC‐Based Cancer Vaccines?

The oncologist (Dayton, Ohio), 2012-10, Vol.17 (10), p.1256-1270

2012

Link zum Volltext

Verfügbarkeit prüfen

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

Pharmaceutics, 2021-03, Vol.13 (3), p.396

2021

Link zum Volltext

Verfügbarkeit prüfen

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands

Frontiers in immunology, 2022-02, Vol.13, p.734256-734256

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

Frontiers in immunology, 2018-11, Vol.9, p.2503-2503

2018

Link zum Volltext

Verfügbarkeit prüfen

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

Journal of hematology and oncology, 2024-02, Vol.17 (1), p.8-8, Article 8

2024

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

Journal of clinical medicine, 2019-04, Vol.8 (5), p.579

2019

Link zum Volltext

Verfügbarkeit prüfen

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation

STAR protocols, 2023-03, Vol.4 (1), p.102112-102112, Article 102112

2023

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Cancers, 2019-09, Vol.11 (9), p.1396

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical use of dendritic cells for cancer therapy

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells

Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells

Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner

NK Cells: Key to Success of DC‐Based Cancer Vaccines?

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands

Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer

Suchergebnisse filtern